These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 14682276)
1. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Single agent therapy for HIV infection? Currier J AIDS Clin Care; 2003 Nov; 15(11):96. PubMed ID: 14682276 [No Abstract] [Full Text] [Related]
2. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Prognosis after triple-class failure. Currier J AIDS Clin Care; 2003 Nov; 15(11):95. PubMed ID: 14682274 [No Abstract] [Full Text] [Related]
3. Highlights of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Prescott LM Body Posit; 2002 Dec; 15(7):16-20. PubMed ID: 14989207 [No Abstract] [Full Text] [Related]
4. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). T-1249 for T-20 salvage. Feinberg J AIDS Clin Care; 2003 Nov; 15(11):95-6. PubMed ID: 14682275 [No Abstract] [Full Text] [Related]
5. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New CCR5 antagonist shows antiretroviral effect. Feinberg J AIDS Clin Care; 2003 Nov; 15(11):94-5. PubMed ID: 14682273 [No Abstract] [Full Text] [Related]
6. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Abacavir as initial therapy and as a once-daily drug. Sax PE AIDS Clin Care; 2003 Nov; 15(11):93-4. PubMed ID: 14682271 [No Abstract] [Full Text] [Related]
7. ICAAC newspaper headlines misleading on protease inhibitor failure. James JS AIDS Treat News; 1997 Oct; (No 281):1-2. PubMed ID: 11364792 [TBL] [Abstract][Full Text] [Related]
8. Selected highlights from ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy). TreatmentUpdate; 2002 Jan; 14(1):5-10. PubMed ID: 12141238 [No Abstract] [Full Text] [Related]
9. ICAAC and Hamburg: Part 1. Schmuddelwetter or, rating protease inhibitors on the pass/fail system. Mascolini M J Int Assoc Physicians AIDS Care; 1997 Dec; 3(12):29-37. PubMed ID: 11364943 [TBL] [Abstract][Full Text] [Related]
10. Anti-HIV agents. Introduction to ICAAC: selected highlights from the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). TreatmentUpdate; 2003 Oct; 15(6):1-2. PubMed ID: 17216859 [No Abstract] [Full Text] [Related]
11. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Suboptimal response to once-daily abacavir + 3TC + tenofovir. Feinberg J AIDS Clin Care; 2003 Nov; 15(11):94. PubMed ID: 14682272 [No Abstract] [Full Text] [Related]
12. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Didanosine intensification in NRTI-experienced patients. Currier J AIDS Clin Care; 2003 Nov; 15(11):96. PubMed ID: 14682278 [No Abstract] [Full Text] [Related]
13. Notes from the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2002. Susman E AIDS; 2003 Jan; 17(2):N1-2. PubMed ID: 12545099 [No Abstract] [Full Text] [Related]
14. Updates from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Whitson S Posit Aware; 1998; 9(6):18-9. PubMed ID: 11366473 [TBL] [Abstract][Full Text] [Related]
15. Half-full or half-empty: no simple answer on protease inhibitor failure. Torres G GMHC Treat Issues; 1997 Oct; 11(10):1-2. PubMed ID: 11364818 [TBL] [Abstract][Full Text] [Related]
17. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New NNRTI resistance mutations. Sax PE AIDS Clin Care; 2003 Nov; 15(11):96. PubMed ID: 14682277 [No Abstract] [Full Text] [Related]
18. ICAAC and Hamburg: Part 2. The dry salvages or, what to do with two protease inhibitors. Mascolini M J Int Assoc Physicians AIDS Care; 1997 Dec; 3(12):39-54. PubMed ID: 11364944 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy: rehashes, leftovers, and a pinch of new data. Gallant JE Hopkins HIV Rep; 1998 Nov; 10(6):1, 4, 9-11. PubMed ID: 11366128 [TBL] [Abstract][Full Text] [Related]
20. Dual PI therapy emerges as most viable combination. AIDS Alert; 1997 Dec; 12(12):133-5. PubMed ID: 11364830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]